Unitree Robotics Clears $619M Shanghai IPO, Becoming China's AI Robot Champion

China’s most internationally recognized robotics company is heading to the public markets. Unitree Robotics, the Hangzhou-based maker of the Go2 robot dog that went viral across global social media, has received final approval from the China Securities Regulatory Commission to list on the Shanghai STAR Market. The company plans to issue at least 40.45 million shares and raise approximately 4.2 billion yuan — around $619 million at current exchange rates — at a target valuation of roughly 40 billion yuan ($6.2 billion).

The approval came in early July, following a regulatory review that the company cleared in just 73 days from formal acceptance of its filing in March 2026. That pace is exceptional even by the STAR Market’s standards — the exchange was designed to fast-track technology companies and has historically moved more quickly than the main boards — and it reflects a deliberate policy signal from Beijing about the priority status of AI-enabled hardware.

A Company That Made Robots Cool

Unitree’s path to the public markets runs through a product strategy that is unusual in Chinese robotics: rather than targeting industrial automation first and consumer awareness second, the company built global brand recognition through robots that people wanted to watch and share.

The Go2 quadruped, released in 2023, became the reference product for “affordable robot dog” in the way that DJI’s early drones defined consumer aerial imaging. At launch prices that undercut Boston Dynamics’ Spot by more than 90%, the Go2 attracted robotics researchers, university labs, and technology enthusiasts who had previously been priced out of legged robotics. Videos of Go2 units navigating rough terrain, dancing, and interacting with people accumulated hundreds of millions of views across YouTube, TikTok, and X.

That brand recognition translated into a business of meaningful scale. In 2025, Unitree reported revenue of 1.699 billion yuan ($250 million), with net profit attributable to shareholders — excluding non-recurring items — of 590 million yuan. The gross profit margin on its core businesses reached 60.13%, an exceptional figure for a hardware manufacturer and one that reflects the software and AI layer increasingly bundled into Unitree’s products.

The Humanoid Pivot

The Go2 and its industrial sibling, the B2, are quadruped platforms. But the business story Unitree is telling investors is increasingly about humanoid robots — bipedal machines designed to operate in environments built for humans.

The company’s H1 humanoid was released in 2023, followed by the more capable G1 in 2024. By 2025, Unitree had begun deliveries of the G1 to enterprise customers in manufacturing and logistics settings, and had accumulated a waiting list that it has not disclosed in full. The IPO proceeds are earmarked partly for AI model research and partly for “robot body development” — the design and manufacturing work required to bring a more capable generation of humanoids to market at a competitive price.

The market Unitree is targeting is genuinely large. Goldman Sachs estimated in early 2026 that the humanoid robot market could reach $38 billion by 2035 in an optimistic scenario, with most of that value accruing to companies that can manufacture at scale and integrate proprietary AI software. Unitree’s position — low-cost manufacturing, strong brand, an accumulating software stack — maps relatively well onto what that market likely rewards.

But it faces competition on multiple fronts. Boston Dynamics’ Atlas has been upgraded with Google’s Gemini Robotics integration, giving it unprecedented reasoning capability for physical tasks. Tesla’s Optimus program has the advantage of Gigafactory scale and vertical integration. And from within China, BYD has quietly entered the humanoid space, as have several startups backed by Tencent and Meituan’s venture arms.

Why the STAR Market, and Why Now

The STAR Market, launched by the Shanghai Stock Exchange in 2019, was explicitly modeled as China’s answer to Nasdaq — a venue where technology and deep-science companies could list without needing to meet the profitability requirements of the main boards. It has become the preferred listing venue for China’s semiconductor companies (SMIC, Cambricon), and is increasingly the natural home for AI hardware champions.

Beijing has been using the STAR Market as an instrument of industrial policy, ensuring that companies in priority sectors receive the regulatory treatment and investor attention they need to fund long capital cycles. Unitree’s 73-day review is the clearest evidence yet that robotics, alongside semiconductors and AI models, has been designated a priority sector for this treatment.

The IPO timing also reflects a favorable window in the China robotics investment narrative. After a period of skepticism about whether humanoid robots could achieve commercial viability on a meaningful timeline, a series of operational deployments in 2025 and 2026 have begun to shift the narrative. CATL is using robot arms in battery assembly; BYD has robots in at least two production facilities. The question has shifted from “will this work?” to “who will win and at what scale?”

What Comes After the IPO

The $619 million raise, if achieved at the target valuation, would make Unitree one of the largest technology IPOs on the STAR Market in 2026 and give the company a war chest that smaller competitors cannot match. The proceeds are specifically allocated to AI model research, robot hardware development, new product categories, and a new smart manufacturing base — a deployment plan that reads as both an R&D investment and a capacity expansion at the same time.

International investors will have limited direct access to the STAR Market listing; the offering is structured primarily for domestic Chinese investors. But Unitree’s global product presence and its export sales — which have been a significant portion of revenue — ensure that its performance will be watched closely by every Western robotics company, every investor benchmarking the humanoid race, and every government tracking the strategic capabilities of Chinese AI hardware.

The listing does not yet have a confirmed date. It follows the regulatory approval stage and typically requires an additional pricing and marketing period. Given the pace Beijing has already shown in processing Unitree’s application, there is little reason to expect further delays.